CBD-O (also called CBD-O-acetate or CBD-di-O-acetate) is a synthetic cannabinoid made by chemically modifying CBD. Unlike naturally occurring CBD, which is extracted directly from hemp plants, CBD-O is created in a lab by adding acetate groups to the CBD molecule. It has appeared in edibles, vape products, and other hemp-derived items, sometimes without being listed on the label.
How CBD-O Differs From Regular CBD
CBD, or cannabidiol, occurs naturally in hemp and cannabis plants. CBD-O is a derivative created through a chemical reaction between CBD and a compound called acetic anhydride. This process attaches acetate groups to the CBD molecule, fundamentally changing its chemical structure. Lab analysis has confirmed that finished CBD-O products typically contain less than 5% of the original CBD compound, meaning the conversion is nearly complete.
The “O” in the name refers to the oxygen-containing acetate ester bond that distinguishes it from standard CBD. This is the same type of chemical modification seen in THC-O-acetate, another synthetic cannabinoid that has drawn regulatory scrutiny. Both belong to a broader category of acetate ester cannabinoids that have emerged in commercially sold products in recent years.
Why CBD-O Exists
CBD-O emerged as part of a wave of novel cannabinoids designed to exploit a gap in federal regulation. The 2018 Farm Bill removed hemp from the Controlled Substances Act, defining legal hemp as cannabis with no more than 0.3% delta-9 THC by dry weight. Manufacturers have interpreted this broadly, creating chemically modified derivatives from hemp-sourced CBD and marketing them as legal hemp products. CBD-O is one of several such compounds, alongside delta-8 THC, THC-O-acetate, and others.
The appeal for manufacturers is straightforward: hemp-derived CBD is cheap and abundant, and chemical modification can produce novel compounds that aren’t explicitly named in federal drug schedules. Whether these synthetic derivatives actually qualify as legal hemp products remains a contested question.
Serious Safety Concerns With Vaping Acetates
The most significant risk associated with CBD-O and other acetate cannabinoids involves heating. When acetate esters are vaped or dabbed, they can break down into ketene, a highly toxic gas. This isn’t theoretical. Laboratory research published in Chemical Research in Toxicology confirmed that ketene forms when cannabinoid acetates are vaped, and it was detectable at temperatures as low as 278°C (about 532°F) on a dab platform. Higher temperatures and battery power increase the amount of ketene produced.
Ketene is extraordinarily dangerous. It attacks the lungs in a manner similar to phosgene, a chemical warfare agent, by destroying proteins and disrupting the barrier between blood and air in lung tissue. This leads to fluid buildup, inflammation, and potentially life-threatening respiratory failure. One documented case involved a chemical worker who developed acute respiratory distress syndrome after just five minutes of exposure to concentrated ketene.
This chemistry is directly relevant to the 2019 EVALI outbreak (e-cigarette or vaping-associated lung injury), which caused 2,807 hospitalizations and 68 deaths in the United States. That outbreak was strongly linked to vitamin E acetate, an additive in some THC vape products. The key finding: when researchers vaped plain vitamin E under the same conditions, no ketene was detected. The acetate group was the critical factor. This means any acetate-based cannabinoid, including CBD-O, carries the same fundamental risk when heated.
Research has shown that as few as 5 to 11 puffs over a 10-minute period could push ketene exposure past the level known to cause serious, irreversible respiratory effects. Ordinary ambient oxygen in the air significantly promotes ketene generation during vaping, making real-world conditions potentially worse than controlled lab settings.
Legal Status Is Unclear
CBD-O occupies a gray area in federal law. The 2018 Farm Bill legalized hemp derivatives with less than 0.3% delta-9 THC, but the FDA retained full authority to regulate cannabis-derived products. The DEA has not issued specific guidance naming CBD-O, though it has signaled that synthetically derived cannabinoids fall outside the Farm Bill’s protections. In early 2023, the DEA confirmed that THC-O-acetate, which is made through the same acetate ester process, is a controlled substance because it does not occur naturally in hemp. The same logic could apply to CBD-O.
Several states have moved independently to ban synthetic cannabinoids, including acetate derivatives. But enforcement is inconsistent, and products containing CBD-O have been found in commercially sold gummies and vape cartridges. In at least one documented case, lab analysis of a gummy product identified CBD-O-acetate that was not mentioned anywhere on the packaging.
No Standardized Testing or Quality Control
Because CBD-O is not regulated as a food additive, supplement, or pharmaceutical, there are no federal testing requirements for purity, potency, or contaminant screening. Standard cannabis testing programs in states like Oregon and Colorado were designed for plant-derived cannabinoids, not synthetic acetate esters. This means products containing CBD-O may not be tested for residual solvents, heavy metals, or the presence of unintended byproducts from the synthesis process.
The lack of oversight also means you have no reliable way to verify what concentration of CBD-O is in a product, whether the conversion was done safely, or whether other unlisted compounds are present. The fact that researchers have already found undisclosed CBD-O in retail products underscores this gap. Without standardized manufacturing processes, batch-to-batch consistency is essentially a gamble.
How CBD-O Compares to Other Cannabinoids
CBD-O is often grouped with THC-O-acetate and delta-8 THC as part of the “alt-cannabinoid” market. The key differences matter:
- CBD is a natural compound extracted from hemp. It does not produce a high and has a well-studied safety profile.
- Delta-8 THC is typically synthesized from CBD through acid-catalyzed conversion. It produces mild psychoactive effects and has faced bans in multiple states.
- THC-O-acetate is a synthetic acetate ester of THC. The DEA has classified it as a controlled substance.
- CBD-O-acetate is a synthetic acetate ester of CBD. Its effects are poorly studied, its legal status is ambiguous, and it carries the same acetate-related inhalation risks as THC-O.
What sets acetate cannabinoids apart from other synthetic derivatives is the specific inhalation danger. The acetate group is the chemical feature responsible for ketene generation when heated. Non-acetate cannabinoids do not produce ketene under the same conditions. This makes the route of consumption, particularly vaping, a critical safety variable that does not apply equally to all synthetic cannabinoids.